Send us Feedback

Teva Pharmaceutical Industries (TEVA)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW
 
 
 
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
Balance Sheet    (USD)
Annual | Quarterly
QUARTER ENDING 31-MAR
2012		 30-JUN
2012		 30-SEP
2012		 31-DEC
2012		 31-MAR
2013
Cash & Equivalents 1.06B 1.19B 1.43B 2.88B 1.39B
Short Term Investments 0 0 0 0 0
Accounts Receivable 6.06B 5.43B 5.78B 5.57B 5.42B
Inventories 5.33B 5.29B 5.46B 5.50B 5.38B
Pre-paid Expenses 0 0 0 0 0
Deferred Tax Assets 2.52B 2.31B 2.31B 1.14B 1.03B
Other Current Assets 0 0 0 1.26B 1.19B
Total Current Assets 15.0B 14.2B 15.0B 16.4B 14.4B
Property, Plant & Equipment 6.08B 6.08B 6.28B 6.32B 6.29B
Goodwill & Intangibles 28.2B 27.3B 27.0B 26.6B 26.0B
Other Long-term Assets 1.04B 1.11B 1.21B 1.34B 1.39B
Total Long-Term Assets 35.5B 34.7B 34.6B 34.3B 33.7B
Total Assets 50.5B 48.9B 49.6B 50.6B 48.1B
Accounts Payable 3.20B 3.02B 3.14B 3.38B 3.14B
Accrued Expenses 0 0 0 0 0
Short Term Debt 4.37B 1.42B 1.10B 3.01B 2.72B
Other Current Liabilities 6.06B 5.56B 6.38B 6.51B 6.49B
Total Current Liabilities 13.6B 10.0B 10.6B 12.9B 12.4B
Long Term Debt 10.2B 12.6B 12.7B 11.7B 9.94B
Capital Lease Obligations 0 0 0 0 0
Deferred Income Tax 2.21B 2.04B 1.91B 1.85B 1.64B
Other Long-term Liabilities 1.28B 1.32B 1.28B 1.29B 1.32B
Total Long-term Liabilities 13.6B 16.0B 15.9B 14.9B 12.9B
Minority Interest 149M 142M 138M 99.0M 100M
Total Liabilities 27.4B 26.1B 26.6B 27.8B 25.4B
Preferred Stock 0 0 0 0 0
Common Par 50.0M 50.0M 50.0M 50.0M 50.0M
Additional Paid-In Capital 13.4B 13.4B 13.5B 13.5B 13.5B
Retained Earnings 11.9B 12.5B 12.2B 12.3B 12.7B
Treasury Stock -2.46B -2.59B -2.59B -3.08B -3.28B
Other Equity 142M -684M -233M -17.0M -251M
Total Shareholder's Equity 23.1B 22.8B 22.9B 22.8B 22.7B
⟩





⟩





⟩





⟩





⟩





⟩





⟩
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
Data Sources:
Market and financial statement data provided by NASDAQ, BATS Exchange, SEC and Xignite Inc. Industry and operating metrics collected from company filings via EDGAR online. For more information on sources and calculations click here.
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki